Nicholas Company’s Alexion Pharmaceuticals ALXN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-48,325	Closed	-$4.73M	–	227
2019 Q3	$4.73M	Sell	48,325 -40	-0.1%	-$4.51K	0.11%	189
2019 Q2	$6.33M	Sell	48,365 -225	-0.5%	-$29K	0.14%	158
2019 Q1	$6.57M	Buy	48,590 +85	+0.2%	+$10.6K	0.16%	150
2018 Q4	$4.72M	Hold	48,505	–	–	0.12%	179
2018 Q3	$6.74M	Buy	48,505 +105	+0.2%	+$13.2K	0.15%	155
2018 Q2	$6.01M	Buy	48,400 +5,630	+13%	+$658K	0.14%	159
2018 Q1	$4.77M	Buy	+42,770	New	+$5.11M	0.11%	182
2017 Q2	–	Sell	-50,265	Closed	-$6.09M	–	223
2017 Q1	$6.09M	Buy	50,265 +40	+0.1%	+$5.16K	0.14%	131
2016 Q4	$6.14M	Buy	50,225 +5,020	+11%	+$614K	0.14%	130
2016 Q3	$5.54M	Buy	45,205 +9,990	+28%	+$1.29M	0.12%	131
2016 Q2	$4.11M	Hold	35,215	–	–	0.08%	153
2016 Q1	$4.9M	Buy	35,215 +2,685	+8%	+$394K	0.1%	127
2015 Q4	$6.21M	Hold	32,530	–	–	0.12%	116
2015 Q3	$5.09M	Hold	32,530	–	–	0.1%	120
2015 Q2	$5.88M	Buy	32,530 +17,520	+117%	+$3.02M	0.1%	124
2015 Q1	$2.6M	Buy	+15,010	New	+$2.72M	0.05%	199